Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Amalgamated Financial Corp. Director's Dealing 2025

Nov 4, 2025

32385_dirs_2025-11-03_e35e6cfa-77a3-489b-8f89-d99acee40e50.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Amalgamated Financial Corp. (AMAL)
CIK: 0001823608
Period of Report: 2025-08-07

Reporting Person: Fox Lynne P. (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2025-08-07 Common Stock S 300 $27.49 Disposed 21914 Direct
2025-10-30 Common Stock M 4820 $12 Acquired 26734 Direct
2025-10-30 Common Stock F 2381 $27.5575 Disposed 24353 Direct
2025-10-30 Common Stock M 7020 $13.75 Acquired 31373 Direct
2025-10-30 Common Stock F 3468 $27.5575 Disposed 27905 Direct
2025-10-30 Common Stock M 6560 $14.65 Acquired 34465 Direct
2025-10-30 Common Stock F 3240 $27.5575 Disposed 31225 Direct
2025-10-31 Common Stock S 8949 $27.3354 Disposed 22276 Direct
2025-11-01 Common Stock A 2568 Acquired 24844 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2025-10-30 Non-Qualified Stock Option (right to buy) $12 M 4820 Disposed 2026-01-01 Common Stock (4820) Direct
2025-10-30 Non-Qualified Stock Option (right to buy) $13.75 M 7020 Disposed 2027-01-01 Common Stock (7020) Direct
2025-10-30 Non-Qualified Stock Option (right to buy) $14.65 M 6560 Disposed 2028-01-01 Common Stock (6560) Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.06 - $27.63 . The reporting person undertakes to provide to AMAL, any security holder of AMAL, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4.

F2: The reported transaction involved the reporting person's receipt of a grant of 2,568 restricted stock units. The restricted stock units vest immediately upon grant, in consideration of the Company's termination of the stock option program and the Director's early exercise of all outstanding and vested stock options on October 30, 2025.